Abstract
Tardive dyskinesia (TD) is a severe and potential irreversible side effect of antipsychotic treatment. Treatment of established TD is often unsuccessful. In this article, we report three cases of psychogeriatric patients who suffered from TD as a side effect of long-term treatment with haloperidol that resolved after switching treatment to aripiprazole. Potential psychopharmacological mechanisms explaining this finding are briefly discussed.
Similar content being viewed by others
References
Abbasian C, Power P (2009) A case of aripiprazole and tardive dyskinesia. J Psychopharmacol 23:214–215
Casey DE (2004) Pathophysiology of antipsychotic drug-induced movement disorders. J Clin Psychiatr 65:25–28
Correll CU, Schenk EM (2008) Tardive dyskinesia and new antipsychotics. Curr Opin Psychiatr 21:151–156
Duggal HS (2003) Aripiprazole-induced improvement in tardive dyskinesia. Can J Psychiatr 48:771–772
Grant MJ, Baldessarini RJ (2005) Possible improvement of neuroleptic-associated tardive dyskinesia during treatment with aripiprazole. Ann Pharmacother 39:1953
Grunder G, Carlsson A, Wong DF (2003) Mechanism of new antipsychotic medications: occupancy is not just antagonism. Arch Gen Psychiatr 60:974–977
Huang NY, Kostrzewa RM, Li C, Perry KW, Fuller RW (1997) Persistent spontaneous oral dyskinesias in haloperidol-withdrawn rats neonatally lesioned with 6-hydroxydopamine: absence of an association with the Bmax for [3H]raclopride binding to neostriatal homogenates. J Pharmacol Exp Ther 280:268–276
Inoue A, Miki S, Seto M, Kikuchi T, Morita S, Ueda H, Misu Y, Nakata Y (1997) Aripiprazole, a novel antipsychotic drug, inhibits quinpirole-evoked GTPase activity but does not up-regulate dopamine D2 receptor following repeated treatment in the rat striatum. Eur J Pharmacol 321:105–111
Klawans HL, Tanner CM, Goetz CG (1988) Epidemiology and pathophysiology of tardive dyskinesia. Adv Neurol 49:185–197
Kostrzewa RM, Huang NY, Kostrzewa JP, Nowak P, Brus R (2007) Modeling tardive dyskinesia: predictive 5-HT2C receptor antagonist treatment. Neurotox Res 11:41–50
Lykouras L, Rizos E, Gournellis R (2007) Aripiprazole in the treatment of tardive dyskinesia induced by other atypical antipsychotics. Prog Neuropsychopharmacol Biol Psychiatr 31:1535–1536
Mamo D, Graff A, Mizrahi R, Shammi CM, Romeyer F, Kapur S (2007) Differential effects of aripiprazole on D(2), 5-HT(2), and 5-HT(1A) receptor occupancy in patients with schizophrenia: a triple tracer PET study. Am J Psychiatr 164:1411–1417
Margolese HC, Chouinard G, Kolivakis TT, Beauclair L, Miller R, Annable L (2005) Tardive dyskinesia in the era of typical and atypical antipsychotics. Part 2: incidence and management strategies in patients with schizophrenia. Can J Psychiatr 50:703–714
Maytal G, Ostacher M, Stern TA (2006) Aripiprazole-related tardive dyskinesia. CNS Spectr 11:435–439
Anonymous (2008) Aripiprazole improves neuroleptic-associated tardive dyskinesia, but it does not meliorate psychotic symptoms. Prog Neuropsychopharmacol Biol Psychiatr 32:1342–1343
Peritogiannis V, Tsouli S, Zafiris S, Pappas D, Mavreas V (2006) Improvement of tardive dyskinesia following amisulpride treatment. Prog Neuropsychopharmacol Biol Psychiatr 30:748–750
Sharma A, Ramaswamy S, Dewan VK (2005) Resolution of ziprasidone-related tardive dyskinesia with a switch to aripiprazole. Prim Care Companion J Clin Psychiatr 7:36
Soares-Weiser K, Fernandez HH (2007) Tardive dyskinesia. Semin Neurol 27:159–169
Tarsy D, Baldessarini RJ (2006) Epidemiology of tardive dyskinesia: is risk declining with modern antipsychotics? Mov Disord 21:589–598
Waddington JL, Cross AJ, Gamble SJ, Bourne RC (1983) Spontaneous orofacial dyskinesia and dopaminergic function in rats after 6 months of neuroleptic treatment. Science 220:530–532
Witschy JK, Winter AS (2005) Improvement in tardive dyskinesia with aripiprazole use. Can J Psychiatr 50:188
Acknowledgements
This work was supported in part by the Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Osorio, R.S., Agüera-Ortiz, L., Hurtado de Mendoza, A. et al. Treatment of Tardive Dyskinesia with Aripiprazole. Neurotox Res 17, 432–434 (2010). https://doi.org/10.1007/s12640-009-9123-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12640-009-9123-0